Travere Therapeutics Inc. buy klostergang
Start price
01.07.19
/
50%
€19.10
Target price
04.11.21
€33.37
Performance (%)
-35.06%
End price
17.06.21
€12.40
Summary
This prediction ended on 17.06.21 with a price of €12.40. Massive losses of -35.06% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Travere Therapeutics Inc. | -5.185% | -5.185% | 14.286% | - |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % | 59,64 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % | 82,45 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % | 59,33 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % | 55,65 % |
Comments by klostergang for this prediction
In the thread Travere Therapeutics Inc. diskutieren
Retrophin mit FDA-Zulassung zur Behandlung von Cystinurie und
fortgeschrittener pipeline: